Search results for " KUBio"

Article A Second Modular Biopharma Facility Opens: KUBio in Hangzhou
GE Healthcare and Pfizer Break Ground on Biopharmaceutical Technology Center To bring advanced biosimilar products to the Chinese market quickly, Pfizer’s Global Biotechnology Center will make u…

Article KUBio modular biopharm facility built in Germany, assembled in China
GE Healthcare is supplying a full biopharmaceutical processing solution, known as a KUBio, to JHL Biotech in Wuhan, China. The sixty-two completed modules that make up the factory have completed the…

Article The story of JHL and KUBio™ facilities
Watch JHL’s biopharmaceutical facility go from concept to completion, from Germany to China, in 18 months.

Article Biopharma in 2016: Higher Quality Drugs, Less Expensive Manufacturing
According to GE, the cost of a KUBio plant can be as much as 45% lower than a comparable, traditional facility This year, Process Development Forum will continue to report on drug approvals, innov…

Article These 17,000 Meters of Land in China will House Advanced Labs and Manufacturing for Future Therapeutics
Leading supplier to the biopharma industry will open a manufacturing facility in Guangzhou using KUBio, the “factory-in-a-box”, to more efficiently deliver targeted treatments. Read the article h…

Article A Q&A on Bioprocessing Trends and Technologies at INTERPHEX 2016
The facility, the first built using the KUBio system (GE Enterprise Solutions), was completed in 18 months. Parrish Galliher, chief technology officer, upstream, GE Healthcare Life Sciences, provided …

Article The Challenges of Adopting Single-Use Technology
For example, for monoclonal antibodies (mAbs), single-use bioreactors (SUBs) of 2000 L are available and "off the shelf" and fully integrated plants at a similar scale such as the KUbio (GE Healthcare…

Article The Good and Bad of Biosimilars
Biosimilars have been around for years, but the biopharma industry – as well as the healthcare community – has been slow to embrace them. Today, however, the competition is really beginning to heat …

Article Biopharma Says It Has an Evolution in New Technologies and Processes
GE Healthcare introduced prefabricated, modular KUBio manufacturing units for the production of viral vector-based therapeutics including viral-vector based vaccines, oncolytic viruses, and gene and c…

Article Managing Risk in Biomanufacturing
We simply cannot avoid all risks and the stakes are high in the biopharmaceutical industry. With patients’ lives dependent on a continuous supply of high-quality drugs and vaccines, it is essential …

Next Page